US Patent Issued to GlaxoSmithKline Intellectual Property Development on May 19 for "IL-18/IL-23 multispecific antigen binding proteins" (British, American Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,625, issued on May 19, was assigned to GlaxoSmithKline Intellectual Property Development Ltd. (Stevenage, Great Britain).

"IL-18/IL-23 multispecific antigen binding proteins" was invented by Sunil Nagpal (Collegeville, Pa.), Helen Payne (Stevenage, Great Britain), Yanxia Guo (Collegeville, Pa.) and Joel Tocker (Collegeville, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides multispecific antigen binding proteins that bind to one or more cytokines, more particularly to pro-inflammatory cytokines. In particular, the present disclosure relates to multispecific antigen binding proteins that comprise an interleukin 18 (IL-...